Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of anti-inflammatory and analgesic agents. Its structure supports the design of active ingredients targeting enzyme inhibition, such as COX-2 inhibitors, due to the presence of the difluoromethyl and amino-pyrazole groups. The methyl ester functionality allows for controlled reactivity in multi-step synthesis, improving bioavailability and metabolic stability in final drug products. Commonly employed in research settings for optimizing lead compounds in medicinal chemistry programs.